Europe is looking at easing travel restrictions on foreign tourists as early as next month, if they are fully vaccinated or come from a country with COVID under control, officials said on Monday (local time).

The European Commission is recommending EU member states agree to restart the bloc's vital tourist industry in time for the European summer after a wipe-out season last year when travel plummeted worldwide.

"Time to revive the EU tourism industry and for cross-border friendships to rekindle - safely," commission chief Ursula von der Leyen tweeted.

But there are caveats. Brussels is seeking to ensure the EU's rapidly accelerating vaccination rollout is not threatened by new virus variants, and that there is reciprocity for Europeans going abroad.

The commission statement said vaccinated people arriving in the EU on "non-essential travel" would need to have received EU-approved jabs, currently those from BioNTech/Pfizer, Moderna, AstraZeneca and Johnson & Johnson.

Even if they are fully immunised - meaning having received two doses, except for the single-jab Johnson & Johnson vaccine, then waiting two weeks for them to be fully effective - EU countries can still require COVID tests, quarantine or even both.

Then there is an "emergency brake" allowing EU countries to halt arrivals from where a "variant of concern or interest is detected", such as those spreading in Brazil, India and South Africa.

"Even vaccinated persons would be subject to the travel restrictions coming from these countries subject to this emergency brake," said a commission spokesman, Adalbert Jahnz.

Meanwhile, Denmark says the COVID-19 vaccine from US pharmaceutical giant Johnson & Johnson will not be included in its national vaccination campaign, citing worries over serious side effects involving blood clots, following a similar move against the AstraZeneca jab.

 

INFECTION RATE

In terms of how the EU would judge whether other countries are doing a good enough job in curbing Covid, the key metric would be their infection rate per 100,000 inhabitants averaged over two weeks.

An EU official involved in drafting the recommendation told journalists an old threshold of 25 infections per 100,000 fixed nearly a year ago would be raised to 100 to reflect "a different reality" because of increasing vaccinations.

Consequently, the EU's list of acceptable countries could expand from seven at the moment - Australia, New Zealand, Rwanda, Singapore, South Korea and Thailand; and China with a thus-far-unmet reciprocity condition - to many more.

Last week, Ms von der Leyen told the New York Times she expected many Americans to be able to return to the EU as tourists for summer, given the US vaccination program.

European countries are keen to welcome back big-spending American tourists under the eased travel restrictions, though the EU official speaking to journalists said the US must first "put its own house in order".

He said he hoped to see "a gradual convergence" of vaccine certificate registration in the US to overcome the current fragmented situation of US states issuing many different certificates, making verification difficult internationally.

The International Tourism Organisation and the World Health Organisation (WHO) were working on certification that would be accepted globally, he noted.

 

RUSSIAN, CHINESE JABS EXCLUDED

While the European Commission recommendation talks about vaccines approved by the European Medicines Agency, it says other COVID-19 vaccines accepted by the WHO for emergency-use jabs may be added later.

As it stands, though, neither Russia's Sputnik V vaccine nor ones made by China would be included, excluding jabs that are used in dozens of lower-income countries.

That goes in the same direction of the EU's planned "digital green certificate" which is also to be launched next month for Europeans to be able to travel more freely within the bloc.

That document will not only show the vaccination status of the bearer, but also recent negative COVID test results, and immunity acquired while recovering from a COVID infection.

 

 

 

COVID VACCINE TRIALS BEGIN ON CHILDREN

Meanwhile, Europe's drugs regulator says it has begun evaluating the use of Pfizer BioNTech's COVID-19 vaccine for 12 to 15-year-olds after a similar request in the United States, a move seen as a crucial step towards achieving herd immunity.

And US biotech firm Novavax said on Monday (local time) it had started clinical trials of its proposed COVID-19 vaccine on children, in a program that will involve up to 3000 adolescents aged 12-17

Far fewer children have been sick with COVID-19 compared to adults, and most have mild to no symptoms, but they can be infected and spread the virus.

Novavax said the trials would test "the efficacy (and) safety" of the vaccine, with participants receiving either the vaccine candidate or placebo in two doses, 21 days apart.

Participants will be monitored for up to two years after their injections. The Novavax vaccine has not yet been authorised in any country, including for adults, but the company plans to file for emergency authorisation in Britain "in the second quarter of 2021", followed by in the United States.

Novavax announced at the end of January that clinical trials conducted in Britain involving 15,000 adults showed 89.3 per cent efficacy.

The Novavax vaccine, which uses different technology from the doses already widely licensed around the world, is a protein-based vaccine engineered from the genetic sequence of the first strain of the coronavirus.

It can be stored at a temperature between 2 and 8 degrees Celsius.

Other vaccine companies including Moderna, Johnson & Johnson and Pfizer are also conducting trials in adolescents.

 

Originally published as Europe looks to re-open, jab trials begin on kids



Students immerse in culture at Yallarm camp

Premium Content Students immerse in culture at Yallarm camp

Students got to build a raft on the Boyne River, participate in activities on...

GPC grows empire with new Bundaberg marine base

Premium Content GPC grows empire with new Bundaberg marine base

The new marine base is expected to provide a number of services including...